JZJizu Zhi

Jizu Zhi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jizu Zhi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Eric M. Burton

    Division of Infectious Diseases, Department of Medicine, Mass General Brigham Hospital, Boston, Massachusetts, United States of America

    1 shared publication
  • Huanzhou Xu

    Affiliation Division of Infectious Disease, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America

    1 shared publication
  • Ibukun A. Akinyemi

    Affiliation Child Health Research Institute, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America

    1 shared publication
  • Lai Jing Su

    Affiliation Child Health Research Institute, Dept. of Pediatrics, University of Florida, Gainesville, Florida, United States of America

    1 shared publication
  • Michael T. McIntosh

    Child Health Research Institute, Department of Pediatrics, University of Florida, Gainesville, FL, USA; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA

    1 shared publication
  • Sumita Bhaduri-McIntosh

    Affiliations Departments of Pediatrics, University of Florida, Gainesville, Florida, United States of America, Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America

    1 shared publication

Latest Publications

  • Open Access

    A heterochromatin inducing protein differentially recognizes self versus foreign genomes

    by Eric M. Burton, Ibukun A. Akinyemi, Tiffany R. Frey, Huanzhou Xu, Xiaofan Li, Lai Jing Su, Jizu Zhi, Michael T. McIntosh, Sumita Bhaduri-McIntosh

    Krüppel-associated box-domain zinc finger protein (KRAB-ZFP) transcriptional repressors recruit TRIM28/KAP1 to heterochromatinize the mammalian genome while also guarding the host by silencing invading foreign genomes. However, how a KRAB-ZFP recognizes target sequences in the natural context of its own or foreign genomes is unclear. Our studies on B-lymphocytes permanently harboring the cancer-causing Epstein-Barr virus (EBV) have shown that SZF1, a KRAB-ZFP, binds to several lytic/replicative phase genes to silence them, thereby promoting the latent/quiescent phase of the virus. As a result, unless SZF1 and its binding partners are displaced from target regions on the viral genome, EBV remains dormant, i.e. refractory to lytic phase-inducing triggers. As SZF1 also heterochromatinizes the cellular genome, we performed in situ footprint mapping on both viral and host genomes in physically separated B-lymphocytes bearing latent or replicative/active EBV genomes. By analyzing footprints, we learned that SZF1 recognizes the host genome through a repeat sequence-bearing motif near centromeres. Remarkably, SZF1 does not use this motif to recognize the EBV genome. Instead, it uses distinct binding sites that lack obvious similarities to each other or the above motif, to silence the viral genome. Virus mutagenesis studies show that these distinct binding sites are not only key to maintaining the established latent phase but also silencing the lytic phase in newly-infected cells, thus enabling the virus to establish latency and transform cells. Notably, these binding sites on the viral genome, when also present on the human genome, are not used by SZF1 to silence host genes during latency. This differential approach towards target site recognition may reflect a strategy by which the host silences and regulates genomes of persistent invaders without jeopardizing its own homeostasis.